Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-052645
Filing Date
2011-09-13
Accepted
2011-09-13 14:08:59
Documents
10
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v234451_10q.htm 10-Q 544863
2 EXHIBIT 31.1 v234451_ex31-1.htm EX-31.1 16705
3 EXHIBIT 32.1 v234451_ex32-1.htm EX-32.1 7518
4 EXHIBIT 99.1 v234451_ex99-1.htm EX-99.1 35872
  Complete submission text file 0001144204-11-052645.txt   2134764

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20110731.xml EX-101.INS 250363
6 XBRL TAXONOMY EXTENSION SCHEMA csbr-20110731.xsd EX-101.SCH 15312
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE csbr-20110731_cal.xml EX-101.CAL 22215
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE csbr-20110731_def.xml EX-101.DEF 52114
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE csbr-20110731_lab.xml EX-101.LAB 125743
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE csbr-20110731_pre.xml EX-101.PRE 71780
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17263 | Film No.: 111087742
SIC: 2836 Biological Products, (No Diagnostic Substances)